Sigmak Lifesciences Sugammadex Sodium Header Sigmak Lifesciences Sugammadex Sodium Header

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Find Radio Compass News for Sugammadex

    Client Email Product

    Sugammadex

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    PRICE INFORMATION

    INTERMEDIATES

    DOSSIERs // Finished Dosage Formulations

    DRUG PRODUCT COMPOSITION

    RELATED EXCIPIENT COMPANIES

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS

    ANALYTICAL SOLUTION(s)

    DIGITAL CONTENT

    PharmaCompass
    Related ProductsRelated Products
    API SUPPLIERS
    API Suppliers

    API Suppliers

    64
    US DMFs Filed

    US DMFs Filed

    28
    CEP/COS Certifications

    CEP/COS Certifications

    0

    JDMFs Filed

    JDMFs Filed

    7
    Other Certificates

    Other Certificates

    12
    Other Suppliers

    Other Suppliers

    51
    API REF. PRICE (USD / KG)
    13,195

    API Market Place

    11
    INTERMEDIATES
    2
    DOSSIERS // FDF
    USA (Orange Book)

    USA (Orange Book)

    15
    Europe

    Europe

    3
    Canada

    Canada

    1
    Australia

    Australia

    0

    South Africa

    South Africa

    2
    Uploaded Dossiers

    Uploaded Dossiers

    11
    GLOBAL SALES (USD Million)

    U.S. Medicaid

    0

    Annual Reports

    917.00

    FDF Market Place

    5
    EXCIPIENTS
    1
    PATENTS & EXCLUSIVITIES

    USFDA Orange Book Patents

    2

    USFDA Exclusivities

    4
    DIGITAL CONTENT

    Blog #PharmaFlow

    2

    News

    23
    REF STANDARD

    EDQM

    0

    USP

    0

    JP

    0

    Other Listed Suppliers

    3
    SERVICES

    0

    left grey arrow
    right gray arrow
    • SOLUTION;INTRAVENOUS - EQ 200MG BASE/2ML (EQ 100MG BASE/ML)
    • SOLUTION;INTRAVENOUS - EQ 500MG BASE/5ML (EQ 100MG BASE/ML)
    Full View ScreenFull Screen View
    Eugia Pharma's Generic Sugammadex Receives Approval in the U.S.
    Eugia Pharma's Generic Sugammadex Receives Approval in the U.S.

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214307

    FDA
    03 Nov 2023
    Share Share
    Sandoz B2B's Generic Sugammadex Receives Approval in the U.S.
    Sandoz B2B's Generic Sugammadex Receives Approval in the U.S.

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214311

    FDA
    13 Oct 2023
    Share Share
    Zydus Pharmaceuticals' Generic Sugammadex Receives Approval in the U.S.
    Zydus Pharmaceuticals' Generic Sugammadex Receives Approval in the U.S.

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214290

    FDA
    04 Oct 2023
    Share Share
    Piramal Critical's sugammadex Receives Approval in Europe
    Piramal Critical's sugammadex Receives Approval in Europe

    https://www.ema.europa.eu/en/documents/overview/sugammadex-piramal-epar-medicine-overview_en.pdf

    EMA
    18 Jul 2023
    Share Share
    AOP Orphan's Sugammadex Approved In Europe
    AOP Orphan's Sugammadex Approved In Europe

    https://www.ema.europa.eu/en/documents/overview/sugammadex-amomed-epar-medicine-overview_en.pdf

    EMA
    06 Jul 2023
    Share Share
    Extrovis' Sugammadex Receives Approval in Europe
    Extrovis' Sugammadex Receives Approval in Europe

    https://www.ema.europa.eu/en/documents/overview/sugammadex-adroiq-epar-medicine-overview_en.pdf

    EMA
    16 Jun 2023
    Share Share
    Mylan's Generic Sugammadex Sodium Receives Approval in the U.S.
    Mylan's Generic Sugammadex Sodium Receives Approval in the U.S.

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213915

    FDA
    15 Jun 2023
    Share Share
    Merck says court ruled in favor over patent-infringement suit Related to BRIDION
    Merck says court ruled in favor over patent-infringement suit Related to BRIDION

    https://www.merck.com/news/u-s-district-court-for-the-district-of-new-jersey-rules-in-favor-of-merck-in-patent-infringement-lawsuit-related-to-bridion-sugammadex/

    PRESS RELEASE
    14 Jun 2023
    Share Share
    Aspiro's Generic Sugammadex Sodium Receives Approval in the U.S.
    Aspiro's Generic Sugammadex Sodium Receives Approval in the U.S.

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214337

    FDA
    09 Jun 2023
    Share Share
    AOP Orphan's Sugammadex Amomed (Sugammadex) Receives Approval in Europe
    AOP Orphan's Sugammadex Amomed (Sugammadex) Receives Approval in Europe

    https://www.ema.europa.eu/en/documents/overview/sugammadex-amomed-epar-medicine-overview_en.pdf

    EMA
    13 Jan 2023
    Share Share
    AOP Orphan's Sugammadex Amomed Receives Approval in Europe
    AOP Orphan's Sugammadex Amomed Receives Approval in Europe

    https://www.ema.europa.eu/en/documents/overview/sugammadex-amomed-epar-medicine-overview_en.pdf

    EMA
    13 Jan 2023
    Share Share
    Zydus gets tentative approval from USFDA for Sugammadex Injection
    Zydus gets tentative approval from USFDA for Sugammadex Injection

    https://health.economictimes.indiatimes.com/news/pharma/zydus-gets-tentative-approval-from-usfda-for-sugammadex-injection/94241549

    ECONOMICTIMES
    16 Sep 2022
    Share Share
    Zydus receives USFDA tentative approval for Sugammadex Injection
    Zydus receives USFDA tentative approval for Sugammadex Injection

    https://www.business-standard.com/article/news-cm/zydus-receives-usfda-tentative-approval-for-sugammadex-injection-122091600629_1.html

    BUSINESS-STANDARD
    16 Sep 2022
    Share Share
    Fresenius Kabi's Sugammadex Receives Approval in the EMA
    Fresenius Kabi's Sugammadex Receives Approval in the EMA

    https://www.ema.europa.eu/en/documents/overview/sugammadex-fresenius-kabi-epar-medicine-overview_en.pdf

    EMA
    21 Jul 2022
    Share Share
    Mylan's Sugammadex Mylan (sugammadex sodium) Receives Approval in Europe
    Mylan's Sugammadex Mylan (sugammadex sodium) Receives Approval in Europe

    https://www.ema.europa.eu/en/medicines/human/EPAR/sugammadex-mylan

    EMA
    22 Nov 2021
    Share Share
    Gland Pharma receives US FDA tentative approval for generic Bridion injection
    Gland Pharma receives US FDA tentative approval for generic Bridion injection

    http://www.pharmabiz.com/NewsDetails.aspx?aid=143137&sid=2

    PHARMABIZ
    09 Oct 2021
    Share Share
    Gland Pharma gets tentative nod from USFDA for generic Sugammadex injection
    Gland Pharma gets tentative nod from USFDA for generic Sugammadex injection

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/gland-pharma-gets-tentative-nod-from-usfda-for-generic-sugammadex-injection/articleshow/86872234.cms

    ECONOMIC TIMES
    08 Oct 2021
    Share Share
    Sugammadex Sodium API – CADIFA Approval by ANVISA
    Sugammadex Sodium API – CADIFA Approval by ANVISA

    https://api.drreddys.com/news/sugammadex-sodium-api-cadifa-approval-anvisa

    PRESS RELEASE
    06 Oct 2021
    Share Share
    Recent developments of Sugammadex Sodium in the wake period of anesthesia
    Recent developments of Sugammadex Sodium in the wake period of anesthesia

    https://www.czpharma.com/industry/122.html

    PRESS RELEASE
    27 Sep 2021
    Share Share
    Introducing Sugammadex Sodium made by Medichem
    Introducing Sugammadex Sodium made by Medichem

    https://www.medichem.es/introducing-sugammadex-sodium-made-by-medichem/

    PRESS RELEASE
    16 Oct 2020
    Share Share
    FDA Confirms Paragraph IV Patent Challenge of Bridion 22225 (Sugammadex Sodium 200 mg/2 mL and 500 mg/5 mL) Injection
    FDA Confirms Paragraph IV Patent Challenge of Bridion 22225 (Sugammadex Sodium 200 mg/2 mL and 500 mg/5 mL) Injection

    https://www.pharmacompass.com/pdf/news/fda-confirms-paragraph-iv-patent-challenge-of-bridion-22225-sugammadex-sodium-200-mg2-ml-and-500-mg5-ml-injection-1581764287.pdf

    FDA
    15 Feb 2020
    Share Share
    First European APIs, Sugammadex and Apixaban, filed to the NMPA
    First European APIs, Sugammadex and Apixaban, filed to the NMPA

    https://www.medichem.es/first-european-apis-sugammadex-and-apixaban-filed-to-the-nmpa/

    PRESS RELEASE
    21 Mar 2019
    Share Share
    Study Stopped as Merck & Co. Immunotherapy Drug Wows in Bladder Cancer Trial
    Study Stopped as Merck & Co. Immunotherapy Drug Wows in Bladder Cancer Trial

    http://www.biospace.com/News/study-stopped-early-as-merck-co-s-immunotherapy/436420/source=TopBreaking?intcid=homepage-seekernewssection-tabtopbreakingnews

    Mark Terry BIOSPACE
    22 Oct 2016
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    Extrovis Sugammadex Sodium

    Access Virtual Booth

    Contact Supplier

    View Presentation

    Asolution Sugammadex Sodium

    Access Virtual Booth

    Contact Supplier

    View Presentation

    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search